850 related articles for article (PubMed ID: 24354597)
21. [THE DEFEAT OF BONE TISSUE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES].
Gabrusskaya TV
Eksp Klin Gastroenterol; 2016; (2):70-8. PubMed ID: 27301121
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
23. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
[TBL] [Abstract][Full Text] [Related]
24. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity.
Joseph AJ; George B; Pulimood AB; Seshadri MS; Chacko A
Indian J Med Res; 2009 Aug; 130(2):133-7. PubMed ID: 19797809
[TBL] [Abstract][Full Text] [Related]
25. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
26. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
[TBL] [Abstract][Full Text] [Related]
27. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
[TBL] [Abstract][Full Text] [Related]
28. Altered bone metabolism in inflammatory bowel disease.
Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
[TBL] [Abstract][Full Text] [Related]
29. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
Klaus J; Reinshagen M; Adler G; Boehm B; von Tirpitz C
BMC Gastroenterol; 2008 Oct; 8():48. PubMed ID: 18947388
[TBL] [Abstract][Full Text] [Related]
30. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
31. Dietary calcium intake in patients with inflammatory bowel disease.
Vernia P; Loizos P; Di Giuseppantonio I; Amore B; Chiappini A; Cannizzaro S
J Crohns Colitis; 2014 Apr; 8(4):312-7. PubMed ID: 24090907
[TBL] [Abstract][Full Text] [Related]
32. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
Ezzat Y; Hamdy K
Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
[TBL] [Abstract][Full Text] [Related]
33. [Bone mineral density in inflammatory bowel diseases in children].
Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
[TBL] [Abstract][Full Text] [Related]
34. Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients.
López-Muñoz P; Beltrán B; Sáez-González E; Alba A; Nos P; Iborra M
Nutrients; 2019 May; 11(5):. PubMed ID: 31083541
[TBL] [Abstract][Full Text] [Related]
35. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
36. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.
Kuwabara A; Tanaka K; Tsugawa N; Nakase H; Tsuji H; Shide K; Kamao M; Chiba T; Inagaki N; Okano T; Kido S
Osteoporos Int; 2009 Jun; 20(6):935-42. PubMed ID: 18825300
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.
Abraham BP; Prasad P; Malaty HM
Dig Dis Sci; 2014 Aug; 59(8):1878-84. PubMed ID: 24619280
[TBL] [Abstract][Full Text] [Related]
39. Evolution of osteopenia in inflammatory bowel disease.
Dinca M; Fries W; Luisetto G; Peccolo F; Bottega F; Leone L; Naccarato R; Martin A
Am J Gastroenterol; 1999 May; 94(5):1292-7. PubMed ID: 10235209
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
Krela-Kaźmierczak I; Szymczak-Tomczak A; Łykowska-Szuber L; Wysocka E; Michalak M; Stawczyk-Eder K; Waszak K; Linke K; Eder P
Adv Clin Exp Med; 2018 Apr; 27(4):449-453. PubMed ID: 29558031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]